9.18
price down icon4.47%   -0.43
after-market アフターアワーズ: 9.18
loading

Omeros Corporation (OMER) 最新ニュース

pulisher
02:46 AM

Omeros Corporation Announces Statistical Analysis Results for Expanded Access ProgramSeattle, Washington–(BUSINESS WIRE)–Feb 20, 2025–Omeros Corporation (NASDAQ: OMER) announced today the statistical analysis results related to the expande - Defense World

02:46 AM
pulisher
Feb 21, 2025

Omeros announces results for narsoplimab expanded access program - Yahoo Finance

Feb 21, 2025
pulisher
Feb 20, 2025

Can This Drug Cut Death Risk by 66% in Transplant Patients? New Data Reveals Breakthrough - StockTitan

Feb 20, 2025
pulisher
Feb 15, 2025

Brokerages Set Omeros Co. (NASDAQ:OMER) Price Target at $22.50 - MarketBeat

Feb 15, 2025
pulisher
Feb 14, 2025

Breakthrough TA-TMA Treatment Data: Narsoplimab Shows Promising Results in 128-Patient Study - StockTitan

Feb 14, 2025
pulisher
Feb 11, 2025

Omeros Co. (NASDAQ:OMER) Given Average Rating of “Moderate Buy” by Analysts - Defense World

Feb 11, 2025
pulisher
Feb 10, 2025

Omeros Corporation Announces Upcoming Presentations Detailing Outcomes of Narsoplimab Treatment for TA-TMA Under an Expanded Access Program - BioSpace

Feb 10, 2025
pulisher
Feb 10, 2025

Omeros Corporation Announces Upcoming Presentations Detailing Outcomes Of Narsoplimab Treatment For Ta-Tma - Marketscreener.com

Feb 10, 2025
pulisher
Feb 10, 2025

Institutions own 43% of Omeros Corporation (NASDAQ:OMER) shares but retail investors control 53% of the company - Yahoo Finance

Feb 10, 2025
pulisher
Feb 07, 2025

SG Americas Securities LLC Has $241,000 Position in Omeros Co. (NASDAQ:OMER) - Defense World

Feb 07, 2025
pulisher
Feb 05, 2025

Navigating OMER Stock: Omeros Corporation Journey - The InvestChronicle

Feb 05, 2025
pulisher
Feb 03, 2025

Stordahl Capital Management Inc. Purchases New Shares in Omeros Co. (NASDAQ:OMER) - MarketBeat

Feb 03, 2025
pulisher
Jan 27, 2025

Omeros (NASDAQ:OMER) Trading Up 5.3%Here's What Happened - MarketBeat

Jan 27, 2025
pulisher
Jan 25, 2025

Omeros (NASDAQ:OMER) Stock Price Down 4.4%Here's Why - MarketBeat

Jan 25, 2025
pulisher
Jan 24, 2025

Omeros jumps as lead drug succeeds in pivotal trial for blood transplant patients - MSN

Jan 24, 2025
pulisher
Jan 23, 2025

Cantor Fitzgerald Forecasts Omeros FY2025 Earnings - Defense World

Jan 23, 2025
pulisher
Jan 22, 2025

Omeros (NASDAQ:OMER) Shares Gap DownTime to Sell? - MarketBeat

Jan 22, 2025
pulisher
Jan 22, 2025

Cantor Fitzgerald Comments on Omeros FY2025 Earnings - MarketBeat

Jan 22, 2025
pulisher
Jan 20, 2025

Omeros’ (OMER) Hold Rating Reiterated at Needham & Company LLC - Defense World

Jan 20, 2025
pulisher
Jan 19, 2025

Barclays PLC Acquires 51,873 Shares of Omeros Co. (NASDAQ:OMER) - MarketBeat

Jan 19, 2025
pulisher
Jan 19, 2025

Barclays PLC Has $376,000 Holdings in Omeros Co. (NASDAQ:OMER) - Defense World

Jan 19, 2025
pulisher
Jan 18, 2025

Omeros (NASDAQ:OMER) Earns “Buy” Rating from D. Boral Capital - Defense World

Jan 18, 2025
pulisher
Jan 18, 2025

Omeros Corporation Announces Statistical Sensitivity Analyses Results for Narsoplimab - Defense World

Jan 18, 2025
pulisher
Jan 17, 2025

Needham & Company LLC Reaffirms Hold Rating for Omeros (NASDAQ:OMER) - MarketBeat

Jan 17, 2025
pulisher
Jan 17, 2025

Omeros (NASDAQ:OMER) Stock Price Up 5.5%Time to Buy? - MarketBeat

Jan 17, 2025
pulisher
Jan 17, 2025

D. Boral Capital Reiterates Buy Rating for Omeros (NASDAQ:OMER) - MarketBeat

Jan 17, 2025
pulisher
Jan 17, 2025

Narsoplimab shows promise in reducing mortality for TA-TMA patients - MSN

Jan 17, 2025
pulisher
Jan 17, 2025

Omeros Co. (NASDAQ:OMER) Given Average Rating of "Moderate Buy" by Analysts - MarketBeat

Jan 17, 2025
pulisher
Jan 17, 2025

Omeros Co. (NASDAQ:OMER) Receives Consensus Recommendation of “Moderate Buy” from Analysts - Defense World

Jan 17, 2025
pulisher
Jan 16, 2025

Personal Finance - Business Wire

Jan 16, 2025
pulisher
Jan 16, 2025

Omeros Announces Update on Statistical Analysis of Narsoplimab Pivotal Trial Primary Endpoint - Business Wire

Jan 16, 2025
pulisher
Jan 12, 2025

Jane Street Group LLC Has $231,000 Stock Holdings in Omeros Co. (NASDAQ:OMER) - Defense World

Jan 12, 2025
pulisher
Jan 11, 2025

When the Price of (OMER) Talks, People Listen - Stock Traders Daily

Jan 11, 2025
pulisher
Jan 09, 2025

Mydriasis Pipeline 2024: Clinical Trials Assessment, FDA Approvals, Therapies, and Key Companies Involved by DelveInsight | Viatris/Ocuphire Pharma, Eyenovia, Rayner Surgical/Omeros, Eyenovia Inc - The Globe and Mail

Jan 09, 2025
pulisher
Jan 09, 2025

United Rentals (URI-N) QuotePress Release - The Globe and Mail

Jan 09, 2025
pulisher
Jan 06, 2025

Omeros (NASDAQ:OMER) Stock Price Down 3.1%Time to Sell? - MarketBeat

Jan 06, 2025
pulisher
Jan 05, 2025

Geode Capital Management LLC Has $5.32 Million Position in Omeros Co. (NASDAQ:OMER) - Defense World

Jan 05, 2025
pulisher
Jan 04, 2025

Omeros Co. (NASDAQ:OMER) Shares Acquired by Barclays PLC - Defense World

Jan 04, 2025
pulisher
Jan 03, 2025

Omeros (NASDAQ:OMER) Trading Up 10.3%Time to Buy? - MarketBeat

Jan 03, 2025
pulisher
Dec 31, 2024

Omeros (NASDAQ:OMER) Shares Gap UpShould You Buy? - MarketBeat

Dec 31, 2024
pulisher
Dec 30, 2024

State Street Corp Has $4.87 Million Stock Position in Omeros Co. (NASDAQ:OMER) - Defense World

Dec 30, 2024
pulisher
Dec 29, 2024

Omeros (NASDAQ:OMER) Shares Up 3.6% – Here’s Why - Defense World

Dec 29, 2024
pulisher
Dec 28, 2024

MML Investors Services LLC Purchases 3,000 Shares of Omeros Co. (NASDAQ:OMER) - Defense World

Dec 28, 2024
pulisher
Dec 27, 2024

Omeros (NASDAQ:OMER) Stock Price Up 3.6%What's Next? - MarketBeat

Dec 27, 2024
$33.42
price up icon 0.27%
$81.06
price down icon 3.05%
$361.10
price down icon 1.70%
$22.12
price down icon 4.08%
biotechnology ONC
$255.37
price up icon 4.57%
$120.01
price up icon 1.81%
大文字化:     |  ボリューム (24 時間):